Jeff Milman was quoted in the New York Times and Law 360 commenting on the April recall announcement made by the FDA stemming from the defects in a radiation therapy shield manufactured by Xoft, Inc. The Xoft Axxent Flexishield Mini is a shielding accessory that is intended to allow patients to avoid traditional post-lumpectomy radiation treatments, however has been found to shed tungsten, a heavy metal compound. At least 27 women with breast cancer – who opted to get a lumpectomy rather than a mastectomy – were treated with the Axxent Flexishield at Hoag Memorial Hospital Presbyterian in Newport Beach, California.  Mr. Milman represents eight of the California women and has filed suit against the manufacturer.

Read More about the Xoft Recall by clicking “Download PDF” above.